Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

PURPOSE: Iodine-131—metaiodobenzylguanidine ((131)I-MIBG) provides targeted radiotherapy with more than 30% response rate in refractory neuroblastoma, but activity infused is limited by radiation safety and hematologic toxicity. The goal was to determine the maximum-tolerated dose of (131)I-MIBG in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Matthay, Katherine K., Quach, Alekist, Huberty, John, Franc, Benjamin L., Hawkins, Randall A., Jackson, Hollie, Groshen, Susan, Shusterman, Suzanne, Yanik, Gregory, Veatch, Janet, Brophy, Patricia, Villablanca, Judith G., Maris, John M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2009
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738616/
https://ncbi.nlm.nih.gov/pubmed/19171714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.15.7628
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia